Who to call at Inhibrx Biosciences, Inc., and when
Fundz watches for the moments Inhibrx Biosciences, Inc. starts buying, and tells you who to reach.
- An alert the day Inhibrx Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inhibrx Biosciences, Inc., from your own LinkedIn network
Inhibrx Biosciences, Inc.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
AI Executive Summary
AI-powered analysis of 8-K filing content
Inhibrx Biosciences updated and posted its corporate presentation on its investor relations website on September 28, 2026, for distribution to the investment community at conferences and meetings. This is a routine investor communication filing with no material business developments disclosed.
Key Takeaways
Company posted updated corporate presentation to investor relations website on September 28, 2026
Presentation is intended for use at investor conferences and meetings to communicate strategic progress
2 more takeaways
Related Filings (2)
2 more filings from Inhibrx Biosciences, Inc. in the last 90 days
Filing Overview
What This Means
Inhibrx Biosciences, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.